Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by wildbird1on Feb 17, 2020 10:40am
171 Views
Post# 30699041

RE:new video on youtube for szls

RE:new video on youtube for szls


Thank's FFinny...great video.

Some on this board pretend that this video doesn't say a lot's. I disagree, lately many new investors came on board and every bit of information is important.

At the 0:30 time SZLS said " Yet 70% of colorectal cancer deaths are attribuated to the 33% of patients who refuse screening, for colonoscopy... patients refuse screening usually because of scheduling challenge, long waiting time, cost  $2,000+US, fear of pain ect... (in the US alone 33% is a huge number of patients).

In the AUG 14, 2019 PressRelease SZLS said " The company has initiated a contract with a Large Health Care System to improve patients compliance with cancer screening."
What SZLS is telling Large Health Care Systems is..., SZLS is not trying to replace Exas: Cologuard $600.00US poop test or colonoscopy(over $2,000 US), no!... SZLS is simply giving doctors and Large Health Care System an alternative for non-compliant patients.

Saving lifes and money.
At the 0.50 time SZLS said" Early stage cancer cost = $33,000US... Late stage cancer cost = $120.000US" a saving of $87,000 for just one patient. Saving $87,000 for just one patient, is on hell of a good sale pitch for a large health care system.

In the medical world it is very difficult to change things and to convince doctors and Large Health Care System to change there way of doing testing, it does take many many years of hard work and a very good stategy.

After many many years of hard work, SZLS is very close to see the results of this non-compliant patients strategy.
                                       

Bullboard Posts